These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7320855)

  • 21. Pharmacokinetics of pirprofen and its pyrrol metabolite in elderly patients.
    Rossi FA; Ferrero M; Balladore GE; Zecca L; Fraschini F; Ferrario P; Bichisao E; Monza GC; Maresca V
    Eur J Clin Pharmacol; 1988; 35(4):379-83. PubMed ID: 3197745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma protein binding of warfarin: methodological considerations.
    Mungall D; Wong YY; Talbert RL; Crawford MH; Marshall J; Hawkins DW; Ludden TM
    J Pharm Sci; 1984 Jul; 73(7):1000-1. PubMed ID: 6470938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pirprofen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Todd PA; Beresford R
    Drugs; 1986 Dec; 32(6):509-37. PubMed ID: 3539573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competition between salicylate and other drugs in binding to human serum protein in vitro.
    Muirden KD; Deutschman P; Phillips M
    Aust N Z J Med; 1974 Apr; 4(2):149-53. PubMed ID: 4528482
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro plasma protein binding of zileuton and its N-dehydroxylated metabolite.
    Machinist JM; Kukulka MJ; Bopp BA
    Clin Pharmacokinet; 1995; 29 Suppl 2():34-41. PubMed ID: 8620669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased rate of clearance of drugs from the circulation of alcoholics.
    Kater RM; Roggin G; Tobon F; Zieve P; Iber FL
    Am J Med Sci; 1969 Jul; 258(1):35-9. PubMed ID: 4894493
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of four sulphonamides to human albumin.
    Zini R; d'Athis P; Hoareau A; Tillement JP
    Eur J Clin Pharmacol; 1976 Jun; 10(2):139-45. PubMed ID: 964290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
    Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of pirprofen to human serum albumin studied by dialysis and spectroscopy techniques.
    Otagiri M; Masuda K; Imai T; Imamura Y; Yamasaki M
    Biochem Pharmacol; 1989 Jan; 38(1):1-7. PubMed ID: 2910295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR; Jain AK; McMahon FG; Vargas R
    Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of modification of albumin on tolbutamide-serum albumin binding.
    Yoshitomi H; Goto S
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2374-9. PubMed ID: 7318045
    [No Abstract]   [Full Text] [Related]  

  • 33. Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.
    Sellers EM; Koch-Weser J
    Clin Pharmacol Ther; 1970; 11(4):524-9. PubMed ID: 5429179
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of tricyclic antidepressants on drug metabolism.
    Pond SM; Graham GG; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1975 Aug; 18(2):191-9. PubMed ID: 50160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.
    Solomon HM; Schrogie JJ; Williams D
    Biochem Pharmacol; 1968 Jan; 17(1):143-51. PubMed ID: 5638549
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative therapeutic activity of pirprofen and acetylsalicylic acid in rheumatoid arthritis. A 12-month controlled multicenter study].
    Roth H; Levasseur YJ; Ryan R
    Nouv Presse Med; 1982 Aug; 11(33):2517-21. PubMed ID: 6752878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of total plasma concentration and age on tolbutamide plasma protein binding.
    Adir J; Miller AK; Vestal RE
    Clin Pharmacol Ther; 1982 Apr; 31(4):488-93. PubMed ID: 7060330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.
    Fernández MC; Erill S; Lucena MI; Pita E; Pérez-Alférez N
    Clin Pharmacokinet; 1985; 10(5):451-5. PubMed ID: 3930124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.